AI brief of an SEC Form 8-K · Rexford Industrial Realty (REXR)

Rexford Industrial names COO Laura Clark CEO effective April 1, 2026; co-CEOs depart

Neutral Impact 4 of 5 leadership Written later

Rexford Industrial's board named Chief Operating Officer Laura Clark as chief executive effective April 1, 2026, succeeding co-CEOs Michael Frankel and Howard Schwimmer, who depart on March 31. Clark joined the board on November 17, 2025, increasing it to eight directors. The company also outlined capital allocation and cost-reduction plans after constructive engagement with Elliott Investment Management, which shareholders may watch as Clark takes over.

Key points

  • Laura Clark, COO since 2024 and CFO from 2020, becomes CEO effective April 1, 2026 and joined the board effective November 17, 2025.
  • Co-CEOs Michael Frankel and Howard Schwimmer each receive a restricted stock award with a fair market value of $22,590,000, plus a $62,500 cash payment for continued board service.
  • The company will add a new independent director by the end of 2025 and projects 2026 G&A of $57 million to $62 million, with $20 million to $25 million of additional net G&A savings.
  • Item 5.02 gives the departure date as March 31, 2025, while the press release gives March 31, 2026.

The filing

CompanyRexford Industrial Realty (REXR)
Form8-K, current report
Filed with the SECNov 18, 2025, 4:22 PM ET
Accession number0001571283-25-000057

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 18, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.